Get started
Award

81702253

Funded outputs count: 7
Funder award ID: 81702253
OpenAlex ID: G405802196
Identification of EphA4 and FGFR1 activation as therapeutic vulnerabilities in EGFR–TKI-resistant NSCLC
2026 · Yueqin Wang, Wenbin Xu, et al. · European journal of medical research
Tumor cell-intrinsic NSUN2 deficiency reprograms macrophages to sensitize non-small cell lung cancer to EGFR inhibitors by reversing immune evasion
2026 · Yueqin Wang, Jingyao Wei, et al. · Neoplasia
Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer
2023 · Yueqin Wang, Jingyao Wei, et al. · Molecular Cancer · 215
PDF
Autocrine EGF and TGF ‐α promote primary and acquired resistance to ALK / c‐Met kinase inhibitors in non‐small‐cell lung cancer
2022 · Yueqin Wang, Yu Zhang, et al. · Pharmacology Research & Perspectives · 8
PDF
Identification of integrative molecular and clinical profiles of Fibrinogen-like protein 2 in gliomas using 1323 samples
2020 · Zhizhen Song, Yueqin Wang, et al. · International Immunopharmacology · 2
Vimentin-targeting AIEgen-peptide conjugates: Wash-free fluorescence detection of EMT-type cancer cells and tissues
2020 · Han Wei, Yifang Yu, et al. · Sensors and Actuators B Chemical · 14
Determination of five nucleosides by LC‐MS/MS and the application of the method to quantify N6‐methyladenosine level in liver messenger ribonucleic acid of an acetaminophen‐induced hepatotoxicity mouse model
2019 · Ruijuan Liu, Fang Zhao, et al. · Journal of Separation Science · 16
Year
Topic